Dupuytrens disease–where to from here?

Main Article Content

David McCombe https://orcid.org/0000-0003-4458-3925


Dupuytren’s, contracture, collagenase, fasciectomy, fasciotomy


The advent of fasciotomy by intralesional collagenase injection has been a significant step forward in the treatment of Dupuytren’s contracture. While the therapeutic benefit of collagenase injection in the treatment of Dupuytren’s contracture has been established, seeking its value relative to the surgery has stimulated an interesting debate about the management of the condition, causing us to examine the results of surgery in more detail. Dupuytren’s disease and its treatment has become topical and will be the subject of the hand surgery symposium at this year’s Plastic Surgery Congress from 30 May – 1 June 2019 at the Melbourne Convention and Exhibition Centre, Victoria, Australia.


Metrics Loading ...
Abstract 2201 | pdf Downloads 266 HTML Downloads 111


1 Livingston R, Wagels M, Heald A. Using collagenase to treat Dupuytren’s disease: a hypothetical cost benefit analysis. Aust J Plast Surg. 2019;2(1):23–30. https://doi.org/10.34239/ajops.v2i1.42
2 Elliott D, Bindra R, Roychowdhury S, Comans T, Fletcher J. Collagenase injections for Dupuytren’s in Australian public hospitals: a cost analysis. Aust J Plast Surg. 2019;2(1):17–22. https://doi.org/10.34239/ajops.v2i1.73
3 Behan F. Dupuytren’s disease: using keystone techniques to improve vascular dynamics. Aust J Plast Surg. 2019;2(1):8–16. https://doi.org/10.34239/ajops.v2i1.134